Itero Biopharmaceuticals Obtains $12,750,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2a68b7e0-6e30-4ba0-807c-dc0f3b522bbf&Preview=1 -
Date
12/31/2008 -
Company Name
Itero Biopharmaceuticals -
Mailing Address
155 Bovet Road San Mateo, CA 94402 -
Company Description
Itero Biopharmaceuticals is focused on developing value-added follow-on and novel therapeutic proteins and
antibodies. -
Website
http://www.iterobiopharm.com -
Transaction Type
Venture Equity -
Transaction Amount
$12,750,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Panorama Capital -
Venture Investor
SV Life Sciences -
Venture Investor
Undisclosed
